Related Experiment Video
Updated: Aug 8, 2026

Plasmid Stability Analysis with Open-Source Droplet Microfluidics
Published on: December 27, 2024
Isolation of plasmid pKM101 in the Stocker laboratory
1SRI International, Biosciences Division, Microbiology Program, 333 Ravenswood Avenue, Menlo Park, CA 94025-3493, United States.
Abstract:
pKM101 is a mutagenesis-enhancing resistance transfer plasmid (R plasmid) that was introduced into several tester strains used in the Salmonella/microsome mutation assay (Ames test). Plasmid pKM101 has contributed substantially to the effectiveness of the Ames assay, which is used on a world-wide basis to detect mutagens and is required by many government regulatory agencies for approval to market new drugs and other chemical agents. Widely used since 1975, the Ames test is still regarded as one of the most sensitive genetic toxicity assays and a useful short-term test for predicting carcinogenicity in animals. Plasmid pKM101, which is a deletion derivative of plasmid R46 (also referred to as R-Brighton after its origin of isolation in Brighton, England), has also been used to elucidate molecular mechanisms of mutagenesis. It was isolated in the laboratory of Professor Bruce A.D. Stocker at Stanford University as part of my doctoral research with 20 R plasmids. Professor Stocker's phenomenal insight into the genetics of Salmonella typhimurium and plasmid behavior was a major factor that led to the isolation of pKM101. This paper includes a tribute to Bruce Stocker, together with a summary of my research with mutagenesis-enhancing R plasmids and a brief discussion of the molecular mechanisms involved in pKM101 plasmid-mediated bacterial mutagenesis.
Insights
The pKM101 plasmid significantly enhances the Salmonella/microsome mutation assay (Ames test), improving the detection of mutagens. This research explores its role in bacterial mutagenesis and its contribution to genetic toxicity testing.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- The Salmonella/microsome mutation assay (Ames test) is a crucial tool for detecting mutagens and assessing genetic toxicity.
- Plasmid pKM101, a derivative of R46, has been instrumental in improving the sensitivity and effectiveness of the Ames test since its introduction.
- The Ames test is widely required by regulatory agencies for the approval of new drugs and chemical agents.
Discussion:
- This paper details the isolation and characterization of pKM101, highlighting its role as a mutagenesis-enhancing R plasmid.
- It explores the molecular mechanisms underlying pKM101-mediated bacterial mutagenesis.
- The research also pays tribute to Professor Bruce A.D. Stocker for his contributions to Salmonella genetics and plasmid research.
Key Insights:
- Plasmid pKM101 has substantially improved the Ames test's ability to detect mutagens.
- pKM101 aids in elucidating the molecular mechanisms of mutagenesis.
- The plasmid is a valuable tool in predicting carcinogenicity and assessing genetic toxicity.
Outlook:
- Continued research into pKM101 will further refine our understanding of bacterial mutagenesis.
- The plasmid's application in genetic toxicity testing is expected to remain significant.
- Further studies may uncover new applications for pKM101 in drug and chemical safety assessments.

